An Unusual Case of Cecal Mesenteric Dedifferentiated Liposarcoma Involving the Ileocolic Artery Resected by Right Hemicolectomy
Total Page:16
File Type:pdf, Size:1020Kb
Contents continued An Unusual Case of Cecal Mesenteric Dedifferentiated Liposarcoma Involving the Ileocolic Artery Resected by Right Hemicolectomy. D. ZHANG, W.D. WILLIAMS, J. LAI (Rochester, NY; Gainesville; Deerfield Beach, FL, USA) .................................................................................................................................................................................... 487 Predictors of Acute Radiation Esophagitis in Non-small Cell Lung Cancer Patients Treated With Accelerated Hyperfractionated Chemoradiotherapy. K. WADA, N. KISHI, N. KANAYAMA, T. HIRATA, Y. UEDA, Y. KAWAGUCHI, M. MORIMOTO, K. KONISHI, F. IMAMURA, K. OGAWA, T. TESHIMA (Osaka) ................. 491 Predictive Factors of Pancreatic Fistula After Pancreaticoduodenectomy and External Validation of Predictive Scores. M. DI MARTINO, I. MORA-GUZMAN, Y.G. BLANCO-TRABA, M.C. DÍAZ, M.A. KHURRAM, E. MARTÍN-PÉREZ (Madrid, Spain; London, UK) .......................................................................................................... 499 Essentiality of Imaging Diagnostic Criteria Specific to Rectal Neuroendocrine Tumors for Detecting Metastatic Lymph Nodes. M. KUDOU, T. ARITA, M. NAKANISHI, Y. KURIU, Y. MURAYAMA, K. SHODA, T. KOSUGA, H. KONISHI, R. MORIMURA, A. SHIOZAKI, H. IKOMA, T. KUBOTA, H. FUJIWARA, K. OKAMOTO, E. OTSUJI (Kyoto, Japan) ........................................................................................................................ 505 Outcomes of Localized Esophageal Squamous Cell Carcinoma Patients Treated With Definitive Concurrent Chemoradiotherapy Using Either Standard or High Radiotherapy Dose: A Retrospective Study Controlling for Organ at Risk Dose. C.-C. LI, H.-Y. FANG, C.-Y. LIN, W.-C. SHEN, C.-R. CHIEN (Taichung; Hsinchu, Taiwan, ROC) ................................................................................................................................................................................... 511 Metabolomics-based Discovery of Serum Biomarkers to Predict the Side-effects of Neoadjuvant Chemoradiotherapy for Esophageal Squamous Cell Carcinoma. S. NISHIUMI, S. FUJIGAKI, T. KOBAYASHI, T. KOJIMA, Y. ITO, H. DAIKO, K. KATO, H. SHOJI, Y. KODAMA, K. HONDA, M. YOSHIDA (Hyogo; Chiba; Tokyo; Kobe, Japan) ............................................................................................................................................. 519 Errata ................................................................................................................................................................................... 527 Contents continued Mesenchymal Stem Cell Marker Expression in Gastric Cancer Stroma. S. NUMAKURA, H. UOZAKI, Y. KIKUCHI, S. WATABE, A. TOGASHI, M. WATANABE (Tokyo, Japan) ................................................................. 387 Prognostic Impact of β2 Adrenergic Receptor Expression in Surgically Resected Pulmonary Pleomorphic Carcinoma. K. KAIRA, M. KAMIYOSHIHARA, O. KAWASHIMA, H. ENDOH, K. IMAIZUMI, M. SUGANO, S. TANAKA, A. FUJITA, Y. KOGURE, A. SHIMIZU, T. OYAMA, T. ASAO, K. SHIMIZU, A. MOGI (Maebashi; Hidaka; Shibukawa; Saku; Toyoake; Takasaki; Isesaki; Ota; Nagoya, Japan) ......................... 395 Prognostic Significance of Pretreatment Lymphocyte–to–Monocyte Ratio in Patients with Tongue Cancer. K. FURUKAWA, G. KAWASAKI, T. NARUSE, M. UMEDA (Sakamoto, Japan) ........................................................ 405 Use of ALK Immunohistochemistry for Optimal Therapeutic Strategy of Pulmonary Large-cell Neuroendocrine Carcinoma and Identification of a Novel KIF5B–ALK Fusion Oncokinase. N. SHIMIZU, Y. AKASHI, T. FUJII, H. SHIONO, K. YANE, T. KITAHARA, Y. OHTA, K. KAKUDO, T. WAKASA (Nara, Japan) ........................... 413 L1CAM as a Negative Prognostic Factor in Endometrioid Endometrial Adenocarcinoma FIGO Stage IA-IB. J. KLAT, A. MLADENKA, J. DVORACKOVA, S. BAJSOVA, O. SIMETKA (Ostrava Poruba, Czech Republic) ..................... 421 Lower Esophageal Sphincter-preserving Anastomosis Is an Acceptable Reconstruction Method Following Laparoscopy-assisted Proximal Gastrectomy. D.J. KIM, W. KIM (Seoul, Republic of Korea) ................................. 425 B-ALL Relapses After Autologous Stem Cell Transplantation Associated With a Shift from e1a2 to e14a2 BCR- ABL Transcripts: A Case Report. S. STELLA, M. MASSIMINO, E. TIRRÒ, S.R. VITALE, L. SCALISE, S. LEOTTA, M.S. PENNISI, A. PUMA, C. ROMANO, F. STAGNO, G. SAPIENZA, G. MILONE, L. MANZELLA (Catania, Italy) ........................................................................................................................................... 431 Polypoid Undifferentiated Carcinoma With Osteoclast-like Giant Cells Arising in the Distal Common Bile Duct: A Rare Case Report. X. LIAO, J. HOULDSWORTH, J. LUO, N. HARPAZ, H. ZHU (New York; Rochester, NY, USA) .................................................................................................................................................................................... 437 PD-1 Expression on Circulating CD8+ T-Cells as a Prognostic Marker for Patients With Gastric Cancer. H. SAITO, S. SHIMIZU, Y. KONO, Y. MURAKAMI, Y. SHISHIDO, K. MIYATANI, T. MATSUNAGA, Y. FUKUMOTO, K. ASHIDA, Y. FUJIWARA (Yonago, Japan) ...................................................................................... 443 Prognostic Significance of Sarcopenia and Systemic Inflammatory Response in Patients With Esophageal Cancer. T. MATSUNAGA, H. MIYATA, K. SUGIMURA, M. MOTOORI, K. ASUKAI, Y. YANAGIMOTO, Y. TAKAHASHI, A. TOMOKUNI, K. YAMAMOTO, H. AKITA, J. NISHIMURA, H. WADA, H. TAKAHASHI, M. YASUI, T. OMORI, M. OUE, M. YANO (Osaka, Japan) ...................................................................................... 449 No Ink on Ductal Carcinoma In Situ : A Single Centre Experience. P. FREGATTI, M. GIPPONI, F. DEPAOLI, F. MURELLI, M. GUENZI, E. BONZANO, M. CEPPI, D. FRIEDMAN (Genoa, Italy) ........................................ 459 Scheduled Intravenous Acetaminophen for Postoperative Management of Patients Who Had Thoracoscopic Esophagectomy for Esophageal Cancer. H. KITAGAWA, T. NAMIKAWA, J. IWABU, S. UEMURA, M. MUNEKAGE, S. TSUDA, K. YOKOTA, M. KOBAYASHI, K. HANAZAKI (Kochi, Japan) ............................... 467 Influence of Neoadjuvant Chemotherapy on Short-term Outcomes After Minimally Invasive Esophagectomy for Esophageal Cancer. D. NOMOTO, N. YOSHIDA, T. AKIYAMA, Y. KIYOZUMI, K. ETO, Y. HIYOSHI, Y. NAGAI, M. IWATSUKI, S. IWAGAMI, Y. BABA, Y. MIYAMOTO, H. BABA (Kumamoto, Japan) .................. 471 Health-related Quality of Life and Toxicity After Single-fraction High-dose-rate Brachytherapy With External Beam Radiotherapy for Localized and Locally Advanced Prostate Cancer. T. MAKINO, K. NAKASHIMA, M. IIJIMA, S. KAWAGUCHI, T. NOHARA, K. SHIGEHARA, K. IZUMI, Y. KADONO, T. KUMANO, A. MIZOKAMI (Kanazawa, Japan) ..................................................................................................................................... 477 Contents continued on the preceding page Contents continued Effective Antiemetic Therapy Is Important With Adjuvant Anthracycline-based Chemotherapy in Breast Cancer. L. TAKALA, M. BÄRLUND, P.-L. KELLOKUMPU-LEHTINE (Tampere, Finland) ............................................. 279 Validation of a Clinical Cancer Register at the Head and Neck Oncology Center in Örebro. E. LUNDIN, M. BERGQVIST, J. AHLGREN, J. REIZENSTEIN, B. LENNERNÄS (Örebro; Gävle; Uppsala, Sweden) ............. 285 Osteoid Osteoma of the Mandible – Clinical and Histological Findings. L. MATTHIES, T. ROLVIEN, T.J. PAKUSA, C. KNIPFER, M. GOSAU, M. AMLING, R.E. FRIEDRICH, J. ZUSTIN (Hamburg, Germany) ........ 291 ® Gene-expression Profiling – A Decision Impact Analysis: Decision Dependency on Oncotype DX as a Function of Oncological Work Experience in 117 Cases. C. EICHLER, J. FROMME, F. THANGARAJAH, J. PUPPE, S. PAEPKE, M. WARM, W. MALTER (Cologne; Munich, Germany) ............................................................................ 297 Positive Association of Male Overactive Bladder Symptoms and Androgen Deprivation: A Nationwide Population-based Cohort Study. J.-R. LI, S.-S. WANG, C.-H. LIN, W.C. DE GROAT, C.-L. CHENG (Taichung, Taiwan, ROC; Pittsburgh, PA, USA) ................................................................................................................................ 305 Assessment of the Applicability of Integrative Tumor Response Assays in Advanced Epithelial Ovarian Cancer. J.-H. KIM, Y.S. YOON, J.C. KIM, Y.-M. KIM (Seoul, Republic of Korea) ............................................................... 313 Expression of Notch 3 and Jagged 1 Is Associated With Merkel Cell Polyomavirus Status and Prognosis in Merkel Cell Carcinoma. L.O. WARDHANI, M. MATSUSHITA, S. KUWAMOTO, D. NONAKA, K. NAGATA, M. KATO, Y. KITAMURA, K. HAYASHI (Yonago, Japan; Surakarta, Indonesia; London; Manchester, UK) ............................... 319 Tumor Resection May Improve Survival in Patients With Soft Tissue Sarcoma Aged 75 Years and Older. T. NAKAMURA, T. OI, K. ASANUMA, T. HAGI, A. SUDO (Mie, Japan) ................................................................. 331 Initiation of Systemic Therapy During the Last 30 Days of Life in Patients with Metastatic Castration-resistant Prostate Cancer. C. NIEDER, E. HAUKLAND, B. MANNSÅKER, A. PAWINSKI, R. YOBUTA, J. NORUM (Tromsø; Bodø; Hammerfest, Norway) ...........................................................................................................................